Stock Events

Stock Events

ALT5 Sigma 

$1.97
116
-$0.14-6.43% Today

Statistics

Day High
2.05
Day Low
1.89
52W High
10.95
52W Low
1.08
Volume
3,535,089
Avg. Volume
4,212,532
Mkt Cap
247.98M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Apr 22
$0.06
Jan 22
$0.46
Oct 21
$0.35
Jul 21
$0.35
Apr 21
$0.17
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

27MarExpected
Q4 0
Q1 2025
Q2 2025
Q4 2025
Next
-0.36
-0.15
0.07
0.28
Expected EPS
-0.18
Actual EPS
N/A

Financials

-49.83%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
25.06MRevenue
-12.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ALTS. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with JanOne in the development of treatments for various diseases, including those JanOne targets with its non-opioid pain management solutions.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical segment, competes in developing medications and treatments that can overlap with JanOne's focus areas, including pain management.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie operates in the pharmaceuticals sector, focusing on innovative therapies, directly competing with JanOne in areas like chronic pain treatment.
Merck
MRK
Mkt Cap214.76B
Merck is involved in the development and manufacturing of drugs that address serious health issues, competing with JanOne in the pharmaceutical space, especially in pain management solutions.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries specializes in generic and specialty medicines, including pain management, making it a competitor to JanOne in the non-opioid pain relief market.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that produces drugs in various therapeutic areas, including pain, competing with JanOne's mission to offer alternative pain solutions.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a biopharmaceutical company that develops medicines in several therapeutic areas, potentially competing with JanOne in the area of pain management.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company focuses on pharmaceuticals in areas that could compete with JanOne, especially considering their work on pain and chronic conditions.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline is a healthcare company that produces pharmaceuticals across various areas, including pain relief, making it a competitor to JanOne.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global life sciences company that offers a broad range of medicines, including those for pain management, competing with JanOne's focus on non-opioid solutions.

About

ALT5 Sigma Corporation operates a next generation blockchain platform. It engages in the tokenization, trading, clearing settlement, payment, and safe keeping of digital assets. The company's products include ALT 5 Prime, an electronic over-the-counter trading platform to buy and sell digital assets; and ALT 5 Pay that enables payment processors to accept digital assets as payments, as well as make payment in digital assets. It is also involved in the developing of solutions for opioid crisis. The company was formerly known as JanOne Inc. and changed its name to ALT5 Sigma Corporation in July 2024. ALT5 Sigma Corporation was founded in 1976 and is based in Las Vegas, Nevada.
Show more...
CEO
Mr. Tony Isaac
Employees
10
Country
US
ISIN
US47089W1045

Listings

F
DE
5AR1.F
XNAS
US
ALTS
BOATS
BOATS
ALTS.BOATS

0 Comments

Share your thoughts

FAQ

What is ALT5 Sigma stock price today?▼
The current price of ALTS is $1.97 USD — it has decreased by -6.43% in the past 24 hours. Watch ALT5 Sigma stock price performance more closely on the chart.
What is ALT5 Sigma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange ALT5 Sigma stocks are traded under the ticker ALTS.
Is ALT5 Sigma stock price growing?▼
ALTS stock has fallen by -1.26% compared to the previous week, the month change is a +62.4% rise, over the last year ALT5 Sigma has showed a -70.23% decrease.
What is ALT5 Sigma market cap?▼
Today ALT5 Sigma has the market capitalization of 247.98M
When is the next ALT5 Sigma earnings date?▼
ALT5 Sigma is going to release the next earnings report on March 27, 2026.
What were ALT5 Sigma earnings last quarter?▼
ALTS earnings for the last quarter are 0.28 USD per share, whereas the estimation was -0.36 USD resulting in a +177.78% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ALT5 Sigma revenue for the last year?▼
ALT5 Sigma revenue for the last year amounts to 25.06M USD.
What is ALT5 Sigma net income for the last year?▼
ALTS net income for the last year is -12.49M USD.
Does ALT5 Sigma pay dividends?▼
Yes, ALTS dividends are paid quarterly. The last dividend per share was 0.06 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does ALT5 Sigma have?▼
As of February 02, 2026, the company has 10 employees.
In which sector is ALT5 Sigma located?▼
ALT5 Sigma operates in the Health Care sector.
When did ALT5 Sigma complete a stock split?▼
The last stock split for ALT5 Sigma was on April 22, 2019 with a ratio of 1:5.
Where is ALT5 Sigma headquartered?▼
ALT5 Sigma is headquartered in Las Vegas, US.